DRREDDY had a strong weekly performance, returning 3.04% with a relatively low volatility of 6.86%. This outperformance was accompanied by a respectable Sharpe Ratio of 1.74, indicating a favorable risk-return tradeoff. Compared to its peers, DRREDDY outperformed SUNPHARMA and HINDUNILVR, but underperformed DIVISLAB. Overall, the stock demonstrated a relatively low-risk profile this week.

[Volatility: 6.86%]